DE602004022136D1 - Leukozyten stimulierende peptide - Google Patents

Leukozyten stimulierende peptide

Info

Publication number
DE602004022136D1
DE602004022136D1 DE602004022136T DE602004022136T DE602004022136D1 DE 602004022136 D1 DE602004022136 D1 DE 602004022136D1 DE 602004022136 T DE602004022136 T DE 602004022136T DE 602004022136 T DE602004022136 T DE 602004022136T DE 602004022136 D1 DE602004022136 D1 DE 602004022136D1
Authority
DE
Germany
Prior art keywords
leukocytes
stimulating peptides
stimulating
peptides
leukocytes stimulating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602004022136T
Other languages
English (en)
Inventor
Sung-Ho Ryu
Yoe-Sik Bae
Eun-Young Park
Pann-Ghill Suh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pohang University of Science and Technology Foundation POSTECH
Posco Holdings Inc
Original Assignee
Posco Co Ltd
Pohang University of Science and Technology Foundation POSTECH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Posco Co Ltd, Pohang University of Science and Technology Foundation POSTECH filed Critical Posco Co Ltd
Publication of DE602004022136D1 publication Critical patent/DE602004022136D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE602004022136T 2003-02-07 2004-02-06 Leukozyten stimulierende peptide Expired - Lifetime DE602004022136D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44562103P 2003-02-07 2003-02-07
PCT/KR2004/000225 WO2004069858A2 (en) 2003-02-07 2004-02-06 Leukocyte stimulating peptides

Publications (1)

Publication Number Publication Date
DE602004022136D1 true DE602004022136D1 (de) 2009-09-03

Family

ID=33029845

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004022136T Expired - Lifetime DE602004022136D1 (de) 2003-02-07 2004-02-06 Leukozyten stimulierende peptide

Country Status (7)

Country Link
US (2) US7074891B2 (de)
EP (1) EP1592704B1 (de)
JP (2) JP4773950B2 (de)
AU (1) AU2004208956B2 (de)
CA (1) CA2515322C (de)
DE (1) DE602004022136D1 (de)
WO (1) WO2004069858A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100630489B1 (ko) 2006-01-10 2006-10-04 주식회사 펩트론 면역반응을 조절하는 펩타이드
EP3548470B1 (de) 2016-12-01 2023-11-01 Promega Corporation 5,5-disubstituierte luciferine und deren verwendung in tests auf luciferase-basis
JP2021534769A (ja) * 2018-08-31 2021-12-16 エーエルエックス オンコロジー インコーポレイテッド デコイポリペプチド
EP4230638A1 (de) * 2022-02-16 2023-08-23 Lipotrue, S.L. Peptide und zusammensetzungen zur verwendung in kosmetika

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000031261A2 (en) 1998-11-25 2000-06-02 Cadus Pharmaceutical Corporation Methods and compositions for identifying effectors of the formyl peptide receptor like-1 (fprl-1) receptor
AU2001241407A1 (en) * 2000-01-31 2001-08-07 Human Genome Sciences, Inc. Nucleic acids, proteins, and antibodies
WO2001096373A2 (en) 2000-06-14 2001-12-20 Clontech Laboratories, Inc. Fluorescent timer proteins and methods for their use
US20020072495A1 (en) 2000-09-21 2002-06-13 Oleg Chertov LL-37 is an immunostimulant
WO2002058714A2 (en) 2001-01-25 2002-08-01 Fondazione Centro San Raffaele Del Monte Tabor Methods and agents modulating upa/upar activity
AU2002332042A1 (en) 2001-10-05 2003-04-22 United States Of America As Represented By The Secretary Of The Navy N-formyl peptide receptor mediation of platelet chemotaxis toward injured cells and activation of immune response
US20030096260A1 (en) 2001-10-09 2003-05-22 Zhenhua Miao Compositions useful as ligands for the formyl peptide receptor like 1 receptor and methods of use thereof

Also Published As

Publication number Publication date
CA2515322C (en) 2011-04-19
US7074891B2 (en) 2006-07-11
JP5137909B2 (ja) 2013-02-06
US20040248255A1 (en) 2004-12-09
EP1592704B1 (de) 2009-07-22
US7622551B2 (en) 2009-11-24
WO2004069858A2 (en) 2004-08-19
JP4773950B2 (ja) 2011-09-14
JP2009261412A (ja) 2009-11-12
AU2004208956A1 (en) 2004-08-19
US20060166888A1 (en) 2006-07-27
CA2515322A1 (en) 2004-08-19
WO2004069858A3 (en) 2004-11-11
JP2006516899A (ja) 2006-07-13
EP1592704A2 (de) 2005-11-09
AU2004208956B2 (en) 2008-11-06

Similar Documents

Publication Publication Date Title
FR17C1024I2 (fr) Polypeptide de facteur viii
DK1478328T3 (da) Bioaktive keratinpeptider
IS7499A (is) Mennsk mótefni gegn beta-amýloíðpeptíðum
DE602005015131D1 (de) Interleukin-15-antagonistisches peptid
DK1653844T3 (da) Prionspecifikke peptidreagenser
DE60327407D1 (de) Immunmodulierende peptide
GB0324265D0 (en) Peptide
EP1666588A4 (de) Neuartiges transporter protein
ATE445634T1 (de) Antimikrobielle peptide
ATE419271T1 (de) Antimikrobielle peptide
DE602004022136D1 (de) Leukozyten stimulierende peptide
DK1625148T3 (da) Peptidkompleks
NO20050436D0 (no) Beta-lagnedbrytende peptider
NO20053512D0 (no) IL-8-liknende proteiner
NO20052608D0 (no) Midkinlignende protein
ATA522002A (de) Vmp-bindungsprotein
SE0200265D0 (sv) Protein complexes
SE0301628D0 (sv) Peptide molecule and use thereof
GB0300717D0 (en) Protein
GB0313629D0 (en) Protein
GB0300089D0 (en) Protein
GB0314067D0 (en) Protein
GB0300719D0 (en) Protein
GB0301253D0 (en) Protein
GB0302773D0 (en) Protein

Legal Events

Date Code Title Description
8364 No opposition during term of opposition